Abstract
Purpose: To develop predictive models for lymph node (LN) metastasis in testicular germ cell tumors. Materials and Methods: 291 patients with testicular germ cell tumors were included, which were divided into seminomatous and nonseminomatous groups. For screening the risk factors for LN metastasis, the tumor-related characteristics (including histopathological information and tumor markers) alpha fetoprotein and the lymph node-related features on CT were compared between metastatic cases and nonmetastatic cases. Two logistic regression models were built for each histological group, one depending on all tumor- and lymph node-related risk factors (Model 1) and another only on tumor-related factors (Model 2). Receivers operating characteristic curves were used to evaluate the predictive abilities of these models. Results: 117 positive nodes/regions were identified in 68 patients, including 51 metastases and 17 occult metastases. Based on the selected independent risk factors, the sensitivity, specificity, accuracy, positive predictive value, and negative predictive value of Models 1 and 2 in seminomatous and nonseminomatous groups were (95.5%, 95.3%, 95.3%, 77.8%, and 99.2%), (63.6%, 83.6%, 80.7%, 40.0%, and 93.0%), (93.5%, 94.7%, 94.3%, 89.6%, and 96.8%), and (89.1%, 44.2%, 58.9%, 43.6%, and 89.4%), respectively. Conclusion: Two predictive models for each seminomatous and nonseminomatous testicular tumor were established based on lymph node- and tumor-related risk factors. In patients with tumor and lymph node-related risk factors, regular CT surveillance is likely sufficient for predicting LN status, while in the patients without any tumor and lymph node-related risk factors a long interval-time CT follow-up should be considered. Additionally, right side tumors tend to involve contralateral LNs compared to left side ones. Positive inguinal LNs more frequently occur in patients with a history of groin surgery.
Similar content being viewed by others
References
Huyghe E, Matsuda T, Thonneau P (2003) Increasing incidence of testicular cancer worldwide: a review. J Urol 170(1):5–11. doi:10.1097/01.ju.0000053866.68623.da
Bosl GJ, Geller NL, Cirrincione C, et al. (1983) Multivariate analysis of prognostic variables in patients with metastatic testicular cancer. Cancer Res 43(7):3403–3407
Aparicio J, Germà JR, García del Muro X, et al. (2005) Risk-adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group study. J Clin Oncol 23(34):8717–8723. doi:10.1200/JCO.2005.01.9810
Albers P, Siener R, Kliesch S, et al. (2003) Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: results of the German Testicular Cancer Study Group Trial. J Clin Oncol 21(8):1505–1512. doi:10.1200/JCO.2003.07.169
Hoskin P, Dilly S, Easton D, et al. (1986) Prognostic factors in stage I non-seminomatous germ-cell testicular tumors managed by orchiectomy and surveillance: implications for adjuvant chemotherapy. J Clin Oncol 4(7):1031–1036
Droz JP, Kramar A, Ghosn M, et al. (1988) Prognostic factors in advanced nonseminomatous testicular cancer. A multivariate logistic regression analysis. Cancer 62(3):564–568
Stoter G, Sylvester R, Sleijfer DT, et al. (1987) Multivariate analysis of prognostic factors in patients with disseminated nonseminomatous testicular cancer: results from a European Organization for Research on Treatment of Cancer Multiinstitutional Phase III Study. Cancer Res 47(10):2714–2718
Rabbani F, Sheinfeld J, Farivar-Mohseni H, et al. (2001) Low-volume nodal metastases detected at retroperitoneal lymphadenectomy for testicular cancer: pattern and prognostic factors for relapse. J Clin Oncol 19(7):2020–2025
Heidenreich A, Sesterhenn IA, Mostofi FK, Moul JW (1998) Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis. Cancer 83(5):1002–1011
Warde P, Gospodarowicz MK, Banerjee D, et al. (1997) Prognostic factors for relapse in stage I testicular seminoma treated with surveillance. J Urol 157(5):1705–1709. (discussion 1709–1710).
Warde P, Specht L, Horwich A, et al. (2002) Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis. J Clin Oncol 20(22):4448–4452
Dong P, Liu Z-W, Li X-D, et al. (2013) Risk factors for relapse in patients with clinical stage I testicular nonseminomatous germ cell tumors. Med Oncol Northwood Lond Engl 30(1):494. doi:10.1007/s12032-013-0494-y
Vergouwe Y, Steyerberg EW, Eijkemans MJC, Albers P, Habbema JDF (2003) Predictors of occult metastasis in clinical stage I nonseminoma: a systematic review. J Clin Oncol 21(22):4092–4099. doi:10.1200/JCO.2003.01.094
Fung CY, Kalish LA, Brodsky GL, Richie JP, Garnick MB (1988) Stage I nonseminomatous germ cell testicular tumor: prediction of metastatic potential by primary histopathology. J Clin Oncol 6(9):1467–1473
Klepp O, Olsson AM, Henrikson H, et al. (1990) Prognostic factors in clinical stage I nonseminomatous germ cell tumors of the testis: multivariate analysis of a prospective multicenter study. Swedish-Norwegian Testicular Cancer Group. J Clin Oncol 8(3):509–518
Aass N, Klepp O, Cavallin-Stahl E, et al. (1991) Prognostic factors in unselected patients with nonseminomatous metastatic testicular cancer: a multicenter experience. J Clin Oncol 9(5):818–826
Williams SB, Kacker R, Winston D, et al. (2011) Predictors of positive retroperitoneal lymph nodes in patients with high risk testicular cancer. J Urol 186(6):2245–2248. doi:10.1016/j.juro.2011.07.101
Vesprini D, Chung P, Tolan S, et al. (2012) Utility of serum tumor markers during surveillance for stage I seminoma. Cancer 118(21):5245–5250. doi:10.1002/cncr.27539
Hermans BP, Sweeney CJ, Foster RS, Einhorn LE, Donohue JP (2000) Risk of systemic metastases in clinical stage I nonseminoma germ cell testis tumor managed by retroperitoneal lymph node dissection. J Urol 163(6):1721–1724
Moul JW, McCarthy WF, Fernandez EB, Sesterhenn IA (1994) Percentage of embryonal carcinoma and of vascular invasion predicts pathological stage in clinical stage I nonseminomatous testicular cancer. Cancer Res 54(2):362–364
Hilton S, Herr HW, Teitcher JB, Begg CB, Castéllino RA (1997) CT detection of retroperitoneal lymph node metastases in patients with clinical stage I testicular nonseminomatous germ cell cancer: assessment of size and distribution criteria. Am J Roentgenol 169(2):521–525. doi:10.2214/ajr.169.2.9242768
Ray B, Hajdu SI, Whitmore WF (1974) Proceedings: distribution of retroperitoneal lymph node metastases in testicular germinal tumors. Cancer 33(2):340–348
Albers P, Albrecht W, Algaba F, et al. (2012) EAU guidelines on testicular cancer: 2011 update. Eur Assoc Urol 36(3):127–145 (Actas Urol Esp). doi:10.1016/j.acuro.2011.06.017
Scatarige JC, Fishman EK, Kuhajda FP, Taylor GA, Siegelman SS (1983) Low attenuation nodal metastases in testicular carcinoma. J Comput Assist Tomogr 7(4):682–687
Hansen J, Jurik AG (2009) Diagnostic value of multislice computed tomography and magnetic resonance imaging in the diagnosis of retroperitoneal spread of testicular cancer: a literature review. Acta Radiol 50(9):1064–1070. doi:10.3109/02841850903220371
Leibovitch L, Foster RS, Kopecky KK, Donohue JP (1995) Improved accuracy of computerized tomography based clinical staging in low stage nonseminomatous germ cell cancer using size criteria of retroperitoneal lymph nodes. J Urol 154(5):1759–1763
Paño B, Sebastià C, Buñesch L, et al. (2011) Pathways of lymphatic spread in male urogenital pelvic malignancies. Radiographics 31(1):135–160. doi:10.1148/rg.311105072
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mao, Y., Hedgire, S., Prapruttam, D. et al. Predictive models for lymph node metastases in patients with testicular germ cell tumors. Abdom Imaging 40, 3196–3205 (2015). https://doi.org/10.1007/s00261-015-0526-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-015-0526-5